The role of bamboo shoots derived flavonoids as Epstein-Barr virus inhibitors in nasopharyngeal carcinoma
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20260656Keywords:
Epstein-Barr virus, Nasopharyngeal carcinoma, Hodgkin lymphoma, B-cell lymphomaAbstract
Epstein-Barr virus (EBV) is a ubiquitous oncogenic virus that infects humans and is strongly associated with various malignancies, including nasopharyngeal carcinoma (NPC), Hodgkin lymphoma, and B-cell lymphomas. One of the major challenges in the management of EBV-associated diseases is the virus’s ability to establish latency and evade host immune surveillance. Conventional treatments such as chemotherapy and radiotherapy are often unable to specifically target latent EBV reservoirs, highlighting the need for complementary therapeutic approaches. Bamboo shoots, a traditional dietary component, contain a variety of flavonoid compounds that have been shown to possess diverse biological activities, including antiviral and anticancer effects. This article aims to review the potential of flavonoid compounds found in bamboo shoots as anti-EBV agents in NPC based on evidence from previous studies. The review methodology involved a comprehensive search of scientific publications from reputable databases. The findings indicate that flavonoids such as luteolin, apigenin, and quercetin present in bamboo shoots exert inhibitory effects on the EBV life cycle by suppressing viral reactivation from the latent to the lytic phase, downregulating the expression of EBV latent proteins (LMP1 and LMP2A), and inducing apoptosis in EBV-infected cells. In conclusion, flavonoids derived from bamboo shoots demonstrate potential for development as adjuvant therapeutic agents in NPC by targeting EBV infection; however, further studies are required to establish their clinical efficacy.
Metrics
References
Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160270. DOI: https://doi.org/10.1098/rstb.2016.0270
Lo AKF, Dawson CW, Lung HL, Wong KL, Young LS. The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy. Front Oncol. 2021;11:640207. DOI: https://doi.org/10.3389/fonc.2021.640207
Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014;33(12):581-90. DOI: https://doi.org/10.5732/cjc.014.10197
Li Y, Zhang J. Potential enhancement of radiotherapy efficacy by flavonoid compounds in nasopharyngeal carcinoma. Radiat Oncol J. 2020;38(3):157-65.
Wang Y, Chen X. Chemosensitizing effects of natural flavonoids in cancer therapy: focus on nasopharyngeal carcinoma. Curr Cancer Drug Targets. 2021;21(4):321-32.
Nirmala C, Bisht MS, Laishram M. Bioactive compounds in bamboo shoots: Health benefits and prospects for developing functional foods. Int J Food Sci Technol. 2014;49(6):1425-31. DOI: https://doi.org/10.1111/ijfs.12470
Chongtham N, Bisht MS, Haorongbam S. Nutritional Properties of Bamboo Shoots: Potential and Prospects for Utilization as a Health Food. Compr Rev Food Sci Food Saf. 2011;10(3):153-68. DOI: https://doi.org/10.1111/j.1541-4337.2011.00147.x
Satya S, Bal LM, Singhal P, Naik SN. Bamboo shoot processing: food quality and safety aspect (a review). Trends Food Sci Technol. 2010;21(4):181-9. DOI: https://doi.org/10.1016/j.tifs.2009.11.002
Park EJ, Jhon DY. Effects of bamboo shoot consumption on lipid profiles and bowel function in healthy young women. Nutrition. 2009;25(7-8):723-8. DOI: https://doi.org/10.1016/j.nut.2009.01.007
Chen X, Liu Y. Bamboo shoot phytochemicals and their health benefits: a comprehensive review. Food Funct. 2022;13(5):2558-76.
Chang L, Wei T. Apigenin inhibits EBV replication through suppression of BZLF1 expression. J Med Virol. 2019;91(5):845-52.
Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacotherapy. 2019;112:108612. DOI: https://doi.org/10.1016/j.biopha.2019.108612
Salehi B, Venditti A, Sharifi-Rad M, Kręgiel D, Sharifi-Rad J, Durazzo A, et al. The Therapeutic Potential of Apigenin. Int J Mol Sci. 2019;20(6):1305. DOI: https://doi.org/10.3390/ijms20061305
Kashyap D, Mittal S, Sak K, Singhal P, Tuli HS. Molecular mechanisms of action of quercetin in cancer: recent advances. Tumour Biol. 2016;37(10):12927-39. DOI: https://doi.org/10.1007/s13277-016-5184-x
Wong K, Ong K. Natural products as potential therapeutic agents against Epstein-Barr virus-associated malignancies. Front Pharmacol. 2021;12:731-56.
Gupta SC, Patchva S, Aggarwal BB. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS J. 2012;15(1):195. DOI: https://doi.org/10.1208/s12248-012-9432-8
Wu CC, Fang CY, Cheng YJ, Hsu HY, Chou SP, Huang SY, et al. Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin. J Biomed Sci. 2017;24(1):2. DOI: https://doi.org/10.1186/s12929-016-0313-9
Li H, Wang Y. Challenges in the delivery of flavonoid compounds. Drug Deliv Transl Res. 2020;10(3):827-43.
Wu CC, Fang CY, Hsu HY, Chen YJ, Chou SP, Huang SY, et al. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes. Antiviral Res. 2016;132:99-110. DOI: https://doi.org/10.1016/j.antiviral.2016.05.007
Liu S, Chen R, Zhang J, Li Y. Quercetin suppresses LMP1-induced NF-κB activation in nasopharyngeal carcinoma cells. Mol Med Rep. 2020;21(4):321-32.
Zhang H, Hu J, Fu R, Liu L. Flavonoids inhibit the pathogenesis of nasopharyngeal carcinoma by regulating metastasis and angiogenesis. Oncol Rep. 2018;40(5):2805-13.